The mortality connected with stem cell transplants includes an extensive range including the kind of distributing (self or allogeneic), detrimental impacts implied on patients because of pre explaining maladies, age and general well being. Discussing the specific risks and success rates is critical with a specoialist is imporatnet. They can offer comprehensive information based on the patient’s health status and unique situation about receiving a transplant.

Only 5% patients experience early death, that is within 1 year. Usually such patients have few comorbidities suggesting their early death is because of underlying disease.

Disclaimer: This is just for information purposes, we are not promoting stem cells.